STIM - Brainsway Continues Growth Trajectory While Conserving Cash
Quick Take
Brainsway (BWAY) went public in April 2019, raising $28 million in gross proceeds from an IPO.
The firm designs and sells non-invasive medical devices to treat psychological disorders.
BWAY continues to produce revenue and gross profit growth and has future growth prospects with ample cash on hand to achieve gains in a challenging economic environment.
My bias on the stock at its current level is cautiously Bullish.
Company
Jerusalem, Israel-based Brainsway was founded in 2003 to develop and sell non-invasive neuromodulation products that use its proprietary Deep Transcranial Magnetic Stimulation (Deep